Skip to main content
Japan Lifeline Co., Ltd. logo

Japan Lifeline Co., Ltd. — Investor Relations & Filings

Ticker · 7575 ISIN · JP3754500001 LEI · 353800QUW6LROZVA6765 T Manufacturing
Filings indexed 73 across all filing types
Latest filing 2024-06-19 Audit Report / Informat…
Country JP Japan
Listing T 7575

About Japan Lifeline Co., Ltd.

https://www.japanlifeline.com/

Japan Lifeline Co., Ltd. is a medical device company specializing in the cardiovascular field. It operates with a hybrid business model, functioning as both a manufacturer of proprietary products and a full-service distributor of advanced medical devices from other global companies. The company's portfolio is focused on treating cardiac diseases, with a strong emphasis on electrophysiology and cardiac rhythm management. Key products include cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), and a range of high-performing cardiac ablation and diagnostic catheters used for treating arrhythmias. The company provides comprehensive solutions and support to medical professionals in the cardiovascular sector.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document text contains Japanese characters and includes the phrase "有価証券報告書" (Yūka Shōken Hōkokusho), which translates to 'Securities Report' or 'Annual Report' in the context of Japanese financial filings. The table headers explicitly mention "【提出書類】確認書" (Filing Document: Confirmation document) and reference the Financial Instruments and Exchange Act ("金融商品取引法"). Furthermore, it confirms the appropriateness of the content for the period ending March 31, 2024, signed by the Representative Director and President. This document is a confirmation statement regarding the accuracy of the Annual Securities Report (which is equivalent to a 10-K in structure/purpose for Japanese listed companies). Since the document is a confirmation/attestation related to the annual filing, and not the full report itself, it is closely related to the Annual Report (10-K) or potentially a general regulatory filing (RNS). However, given the explicit reference to the annual report's content verification, it strongly pertains to the annual reporting cycle. In the provided schema, 10-K is defined as the 'Official yearly report covering company activity and full financial performance.' A confirmation document related to this annual report is best categorized as a specific regulatory filing related to the annual disclosure, but since the core subject is the annual report verification, and it is a short confirmation document, it might fall under RNS if a more specific confirmation code isn't available. Given the context of confirming the *Annual Report* content, and the document being very short (585 chars), it is likely a cover or confirmation attached to the main filing. If this confirmation is filed separately or is the primary document provided, it functions as a regulatory filing. Since there is no specific code for 'Annual Report Confirmation,' and it is not the full 10-K, I will classify it as a Regulatory Filing (RNS) as it is a specific, short regulatory confirmation document related to the annual disclosure process, or potentially an Audit Report (AR) if it were an auditor's confirmation, but here it is management's confirmation. Given the strong link to the annual filing cycle, and the document being a 'Confirmation' (確認書), RNS is the most appropriate fallback for a specific, non-standard regulatory document. FY 2024
2024-06-19 Japanese
臨時報告書
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled "臨時報告書" (Extraordinary Report or Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau. Section 1, "提出理由" (Reason for Submission), states that the report is filed based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act due to a change in the principal shareholder following a tender offer (self-share repurchase). Section 2 details the change in ownership percentages for the outgoing and incoming principal shareholders. This structure—a formal filing announcing a significant change in major shareholding resulting from a tender offer—most closely aligns with a notification of a major shareholding change. Among the provided codes, 'MRQ' (Major Shareholding Notification) is the most appropriate fit for reporting changes in significant share ownership levels crossing thresholds, even though the trigger here is a tender offer settlement. The document is a formal regulatory filing announcing a specific event, not the full annual report (10-K) or an earnings release (ER). Given the specific nature of reporting changes in major shareholders, MRQ is selected over the general fallback RNS.
2024-06-04 Japanese
公開買付報告書
M&A Activity Classification · 100% confidence The document title is explicitly stated as "公開買付報告書" (Tender Offer Report). The filing details reference the "発行者による上場株券等の公開買付けの開示に関する内閣府令" (Cabinet Office Ordinance on Disclosure of Tender Offer for Listed Share Certificates, etc. by Issuer). The content discusses the tender offer period, the number of shares tendered, and the results of the purchase. This clearly indicates a filing related to a takeover bid or tender offer, which corresponds to the M&A Activity category (TAR).
2024-06-04 Japanese
公開買付届出書
M&A Activity Classification · 100% confidence The document is titled "公開買付届出書" (Tender Offer Registration Statement) and explicitly details the intention and mechanics of a tender offer for the company's own shares (self-tender offer or share repurchase via tender offer). Key sections discuss the purpose of the acquisition (shareholder benefit, capital efficiency), the calculation of the tender offer price (based on market price less a discount), the tender offer period, and the number of shares sought. This structure and content align perfectly with filings related to transactions in a company's own shares, specifically a tender offer for repurchase. The relevant category is 'Transaction in Own Shares' (POS).
2024-05-02 Japanese
臨時報告書
Share Issue/Capital Change Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director on May 1, 2024. Section 1 explicitly states the reason for filing is pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 2-2 of the Cabinet Office Ordinance on Disclosure of Corporate Information, concerning a resolution by the Board of Directors to dispose of treasury stock to an Employee Stock Ownership Plan (ESOP) under a restricted stock incentive plan. This structure—a formal filing triggered by a specific corporate action (stock issuance/disposal) under Japanese financial regulations—is characteristic of a timely disclosure filing. Since the content details the specifics of issuing shares (capital change/financing activity) to employees via an ESOP, it strongly aligns with 'Capital/Financing Update' (CAP) or potentially a general 'Regulatory Filing' (RNS). Given the detailed nature of the stock disposal (number of shares, price, terms of restriction, transfer restrictions), 'Capital/Financing Update' (CAP) is the most specific fit, as it concerns capital structure changes via stock issuance/disposal. However, the document type itself is a '臨時報告書' (Timely Disclosure Report), which often falls under the general regulatory category if a more specific one isn't available. Since 'CAP' covers fundraising/capital structure changes, and this is a disposal of treasury stock for an incentive plan, CAP is appropriate. If CAP were not available, RNS would be the fallback. Given the options, CAP is the best fit for the substance of the transaction.
2024-05-01 Japanese
四半期報告書-第44期第3四半期(2023/10/01-2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Japan Lifeline Co., Ltd. for the third quarter of the 44th fiscal year (period ending December 31, 2023). It contains detailed financial statements, management analysis (MDA), and audit review information. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements, it is classified as an Interim/Quarterly Report. 9M 2024
2024-02-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.